Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 2-5 September 2019
PRAC starts review of data on skin cancer with Picato EMA’s safety committee (PRAC) has started a review of data on skin cancer in patients using Picato (ingenol mebutate), a gel for treating actinic keratosis, a skin condition caused by too much sunlight exposure. The review was triggered by data from several studies showing a […]